International journal of clinical pharmacology and therapeutics
Hemoglobin A1c levels in patients with type 2 diabetes mellitus receiving oral semaglutide with versus without proton pump inhibitors: An exploratory study.
Satoru Matsunuma, Yusuke Hirota, Koichi Yoshimoto
Published: 202610.5414/CP204899
Abstract
OBJECTIVE: Oral semaglutide contains salcaprozate sodium, which promotes the opening of epithelial tight junctions and increases gastric pH to prevent its degradation; these actions together improve absorption. Proton pump inhibitors (PPIs) increase…
Preview only. Read the full abstract at the source